Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes

Journal of Controlled Release

Volumn 116, Issue 2 SPEC. ISS., 2006, Pages 211-218

  Capi, Oren ^a,b   Gepstein, Lior ^a,b  

^a Sohnis Family Research Laboratory for the Regeneration of Functional Myocardiumand the Rappaport Fam   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cardiomyocytes; Heart failure; Human embryonic stem cells; Tissue engineering

Indexed keywords

BIOLOGICAL ORGANS; CARDIOLOGY; CELLS; CYTOLOGY; DISEASES; MEDICAL PROBLEMS;

CARDIOMYOCYTES; CELL REPLACEMENT; HEART FAILURE; HUMAN EMBRYONIC STEM CELLS; MYOCARDIAL CELLS; TISSUE ENGINEERING;

TISSUE CULTURE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL REGENERATION; CELL SELECTION; CELL ULTRASTRUCTURE; EMBRYONIC STEM CELL; GOOD MANUFACTURING PRACTICE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INNER CELL MASS; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SCALE UP; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 33845298938     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.06.027     Document Type: Article

References (62)

1. Cohn J.N., Bristow M.R., Chien K.R., Colucci W.S., Frazier O.H., Leinwand L.A., Lorell B.H., Moss A.J., Sonnenblick E.H., Walsh R.A., Mockrin S.C., and Reinlib L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 95 (1997) 766-770
2. Reinlib L., and Field L. Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation 101 (2000) 182-187
3. Murry C.E., Field L.J., and Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112 (2005) 3174-3183
4. Laflamme M.A., and Murry C.E. Regenerating the heart vol. 23 (2005) 845-856
5. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D., and Kraus W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998) 929-933
6. Murry C.E., Wiseman R.W., Schwartz S.M., and Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 98 (1996) 2512-2523
7. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., Schwartz K., Vilquin J.T., and Marolleau J.P. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
8. Soonpaa M.H., Koh G.Y., Klug M.G., and Field L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 264 (1994) 98-101
9. Koh G.Y., Soonpaa M.H., Klug M.G., Pride H.P., Cooper B.J., Zipes D.P., and Field L.J. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs. J. Clin. Invest. 96 (1995) 2034-2042
10. Leor J., Patterson M., Quinones M.J., Kedes L.H., and Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?. Circulation 94 (1996) 332-336
11. Roell W., Fan Y., Xia Y., Stoecker E., Sasse P., Kolossov E., Bloch W., Metzner H., Schmitz C., Addicks K., Hescheler J., Welz A., and Fleischmann B.K. Cellular cardiomyoplasty in a transgenic mouse model. Transplantation 73 (2002) 462-465
12. Bloch W., Fleischmann B.K., Lorke D.E., Andressen C., Hops B., Hescheler J., and Addicks K. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 43 (1999) 675-684
13. Klug M.G., Soonpaa M.H., Koh G.Y., and Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98 (1996) 216-224
14. Anversa P., and Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 415 (2002) 240-243
15. Ma J., Ge J., Zhang S., Sun A., Shen J., Chen L., Wang K., and Zou Y. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction vol. 100 (2005) 217-223
16. Fuchs S., Satler L.F., Kornowski R., Okubagzi P., Weisz G., Baffour R., Waksman R., Weissman N.J., Cerqueira M., Leon M.B., and Epstein S.E. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study vol. 41 (2003) 1721-1724
17. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., and Goodell M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107 (2001) 1395-1402
18. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
19. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., Maat A.P., and Serruys P.W. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42 (2003) 2063-2069
20. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., Bel A., Sarateanu S., Scorsin M., Schwartz K., Bruneval P., Benbunan M., Marolleau J.P., and Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41 (2003) 1078-1083
21. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364141-148 (2004)
22. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., Grunwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., and Zeiher A.M. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
23. Reinecke H., Zhang M., Bartosek T., and Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 10.193-202 (1999)
24. Muller-Ehmsen J., Peterson K.L., Kedes L., Whittaker P., Dow J.S., Long T.I., Laird P.W., and Kloner R.A. Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 105 (2002) 1720-1726
25. Li R.K., Mickle D.A., Weisel R.D., Mohabeer M.K., Zhang J., Rao V., Li G., Merante F., and Jia Z.Q. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 96 (1997) II-179-II-186 discussion 186-177
26. Etzion S., Battler A., Barbash I.M., Cagnano E., Zarin P., Granot Y., Kedes L.H., Kloner R.A., and Leor J. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J. Mol. Cell. Cardiol. 33 (2001) 1321-1330
27. Scorsin M., Hagege A.A., Marotte F., Mirochnik N., Copin H., Barnoux M., Sabri A., Samuel J.L., Rappaport L., and Menasche P. Does transplantation of cardiomyocytes improve function of infarcted myocardium?. Circulation 96 (1997) II-188-II-193
28. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
29. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18 (2000) 399-404
30. Weissman I.L., Anderson D.J., and Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17 (2001) 387-403
31. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
32. Martin G. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 7635
33. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., and Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19 (2001) 1134-1140
34. Zhang S.C., Wernig M., Duncan I.D., Brustle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19 (2001) 1129-1133
35. Assady S., Maor G., Amit M., Itskovitz-Eldor J., Skorecki K.L., and Tzukerman M. Insulin production by human embryonic stem cells. Diabetes 50 (2001) 1691-1697
36. Kaufman D.S., Hanson E.T., Lewis R.L., Auerbach R., and Thomson J.A. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10716-10721
37. Levenberg S., Golub J.S., Amit M., Itskovitz-Eldor J., and Langer R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4391-4396
38. Lavon N., Yanuka O., and Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 72 (2004) 230-238
39. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah O., Itskovitz-Eldor J., and Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108 (2001) 407-414
40. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93 (2003) 32-39
41. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den B.S., Hassink R., van der H.M., Opthof T., Pera M., de la Riviere A.B., Passier R., and Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
42. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. 91 (2002) 501-508
43. Snir M., Kehat I., Gepstein A., Coleman R., Itskovitz-Eldor J., Livne E., and Gepstein L. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2355-H2363
44. Satin J., Kehat I., Caspi O., Huber I., Arbel G., Izhaki I., Magyar J., Schroder E.A., Perlman I., and Gepstein L. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. (2004)
45. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., and Gepstein L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in-vitro model for the study of conduction. Circ. Res. (2002)
46. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., Marini R., van Blitterswijk C.A., Mulligan R.C., D'Amore P.A., and Langer R. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 23 (2005) 879-884
47. Reinecke H., MacDonald G.H., Hauschka S.D., and Murry C.E. Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. J. Cell Biol. 149 (2000) 731-740
48. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., Huber I., Satin J., Itskovitz-Eldor J., and Gepstein L. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22 (2004) 1282-1289
49. Xue T., Cho H.C., Akar F.G., Tsang S.Y., Jones S.P., Marban E., Tomaselli G.F., and Li R.A. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 111 (2005) 11-20
50. Richards M., Fong C.Y., Chan W.K., Wong P.C., and Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20 (2002) 933-936
51. Cripps R.M., and Olson E.N. Control of cardiac development by an evolutionarily conserved transcriptional network. Dev. Biol. 246 (2002) 14-28
52. Harvey R.P. Patterning the vertebrate heart. Nat. Rev. Genet. 3 (2002) 544-556
53. Olson E.N. Development. The path to the heart and the road not taken. Science 291 (2001) 2327-2328
54. Zaffran S., and Frasch M. Early signals in cardiac development. Circ. Res. 91 (2002) 457-469
55. Nascone N., and Mercola M. An inductive role for the endoderm in Xenopus cardiogenesis. Development 121 (1995) 515-523
56. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., van der Heyden M., Opthof T., Pera M., de la Riviere A.B., Passier R., and Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
57. Monzen K., Nagai R., and Komuro I. A role for bone morphogenetic protein signaling in cardiomyocyte differentiation vol. 12 (2002) 263-269
58. Muller M., Fleischmann B.K., Selbert S., Ji G.J., Endl E., Middeler G., Muller O.J., Schlenke P., Frese S., Wobus A.M., Hescheler J., Katus H.A., and Franz W.M. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J. 14 (2000) 2540-2548
59. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., Pasumarthi K.B., and Field L.J. Scalable production of embryonic stem cell-derived cardiomyocytes vol. 9 (2003) 767-778
60. Bradley J.A., Bolton E.M., and Pedersen R.A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2 (2002) 859-871
61. Drukker M., Katz G., Urbach A., Schuldiner M., Markel G., Itskovitz-Eldor J., Reubinoff B., Mandelboim O., and Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9864-9869
62. Drukker M., Katchman H., Katz G., Even-Tov F.S., Shezen E., Horenstein E., Mandelboim O., Reisner Y., and Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem Cells (2005)